Direct Proinflammatory Effect of C-Reactive Protein on Human Endothelial Cells
Top Cited Papers
- 31 October 2000
- journal article
- other
- Published by Wolters Kluwer Health in Circulation
- Vol. 102 (18) , 2165-2168
- https://doi.org/10.1161/01.cir.102.18.2165
Abstract
Background —The acute-phase reactant C-reactive protein (CRP) is an important risk factor for coronary heart disease. However, the possible effects of CRP on vascular cells are not known. Methods and Results —We tested the effects of CRP on expression of adhesion molecules in both human umbilical vein and coronary artery endothelial cells. Expression of vascular cell adhesion molecule (VCAM-1), intercellular adhesion molecule (ICAM-1), and E-selectin was assessed by flow cytometry. Incubation with recombinant human CRP (10 μg/mL) for 24 hours induced an ≈10-fold increase in expression of ICAM-1 and a significant expression of VCAM-1, whereas a 6-hour incubation induced significant E-selectin expression. Adhesion molecule induction was similar to that observed in endothelial cells activated with interleukin-1β. In coronary artery endothelial cells, induction of ICAM-1 and VCAM-1 was already present at 5 μg/mL and reached a maximum at 50 μg/mL, at which point a substantial increase in expression of E-selectin was also evident. The CRP effect was dependent on presence of human serum in the culture medium, because no effect was seen in cells cultured with serum-free medium. In contrast, interleukin-1β was able to induce adhesion molecule expression in the absence of human serum. Conclusions —CRP induces adhesion molecule expression in human endothelial cells in the presence of serum. These findings support the hypothesis that CRP may play a direct role in promoting the inflammatory component of atherosclerosis and present a potential target for the treatment of atherosclerosis.Keywords
This publication has 11 references indexed in Scilit:
- C-Reactive Protein and Other Markers of Inflammation in the Prediction of Cardiovascular Disease in WomenNew England Journal of Medicine, 2000
- Modulation of Vascular Inflammation In Vitro and In Vivo by Peroxisome Proliferator–Activated Receptor-γ ActivatorsCirculation, 2000
- The Major Receptor for C-Reactive Protein on Leukocytes Is Fcγ Receptor IIThe Journal of Experimental Medicine, 1999
- C-Reactive Protein as a Cardiovascular Risk FactorCirculation, 1999
- Regulation of complement activation by C-reactive proteinImmunopharmacology, 1999
- Inflammation, Aspirin, and the Risk of Cardiovascular Disease in Apparently Healthy MenNew England Journal of Medicine, 1997
- Inflammation, Atherosclerosis, and Ischemic Events — Exploring the Hidden Side of the MoonNew England Journal of Medicine, 1997
- Molecular Determinants of Atherosclerotic Plaque VulnerabilityaAnnals of the New York Academy of Sciences, 1997
- Production of C-reactive protein and risk of coronary events in stable and unstable anginaThe Lancet, 1997
- The Prognostic Value of C-Reactive Protein and Serum Amyloid A Protein in Severe Unstable AnginaNew England Journal of Medicine, 1994